Literature DB >> 7718027

Increase in epsilon(gamma-glutamyl)lysine crosslinks in atherosclerotic aortas.

J M Bowness1, M Venditti, A H Tarr, J R Taylor.   

Abstract

Portions of aortas from normal and atherosclerotic rabbits and from human autopsy subjects were washed and separated into layers which were subjected to exhaustive proteolytic digestion. The digests were assayed for epsilon(gamma-glutamyl)lysine crosslinks by a two-stage high performance liquid chromatography (HPLC) procedure. Crosslink concentrations in intima-media from rabbits where more than 15% of the aorta lumen surface was lesioned are greater than in normal aortas or aortas with less than 15% of the surface lesioned. Higher crosslink concentrations occur in fibrolipid plaques from human aortas than in intima-media layers of equal thickness from non-lesioned areas of the same aortas. Much of the crosslink in fibrolipid plaques occurs in the proteins which float at d < 1.18 g/ml. Non-lesioned areas of intima-media from aortas with fatty streaks or plaques have higher crosslink concentrations than intima-media from aortas with no lesions. In normal and lesioned intimas thinner than 0.2 mm, the concentration of the crosslink is lower than in the subjacent media. These findings indicate that increased epsilon(gamma-glutamyl)lysine crosslinking occurs in the atherosclerotic aorta and is associated principally with smooth muscle cells. It is suggested that the crosslinked products may be involved in retention of lipoproteins and the increase in collagen production.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7718027     DOI: 10.1016/0021-9150(94)90099-x

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  12 in total

1.  [Cross-linking in an artificial human cornea via induction of tissue transglutaminases].

Authors:  N Kopsachilis; I Tsinopoulos; K T Tsaousis; R Meiller; S A Dimitrakos; F E Kruse; U W Luessen
Journal:  Ophthalmologe       Date:  2012-06       Impact factor: 1.059

Review 2.  Roles of transglutaminases in cardiac and vascular diseases.

Authors:  David C Sane; Jimmy L Kontos; Charles S Greenberg
Journal:  Front Biosci       Date:  2007-01-01

3.  Hierarchies in the binding of human factor XIII, factor XIIIa, and endothelial cell transglutaminase to human plasma fibrinogen, fibrin, and fibronectin.

Authors:  K E Achyuthan; T C Rowland; P J Birckbichler; K N Lee; P D Bishop; A M Achyuthan
Journal:  Mol Cell Biochem       Date:  1996-09-06       Impact factor: 3.396

Review 4.  Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.

Authors:  Morten A Karsdal; Tina Manon-Jensen; Federica Genovese; Jacob H Kristensen; Mette J Nielsen; Jannie Marie B Sand; Niels-Ulrik B Hansen; Anne-Christine Bay-Jensen; Cecilie L Bager; Aleksander Krag; Andy Blanchard; Henrik Krarup; Diana J Leeming; Detlef Schuppan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-03-12       Impact factor: 4.052

5.  The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis.

Authors:  T S Johnson; M Griffin; G L Thomas; J Skill; A Cox; B Yang; B Nicholas; P J Birckbichler; C Muchaneta-Kubara; A Meguid El Nahas
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

6.  Increase in transglutaminase and its extracellular products in response to an inflammatory stimulus by lipopolysaccharide.

Authors:  J M Bowness; A H Tarr
Journal:  Mol Cell Biochem       Date:  1997-04       Impact factor: 3.396

Review 7.  Transglutaminse 2 and EGGL, the protein cross-link formed by transglutaminse 2, as therapeutic targets for disabilities of old age.

Authors:  William Bains
Journal:  Rejuvenation Res       Date:  2013-12       Impact factor: 4.663

8.  Tissue transglutaminase expression and activity in normal and glaucomatous human trabecular meshwork cells and tissues.

Authors:  Tara Tovar-Vidales; Rouel Roque; Abbot F Clark; Robert J Wordinger
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-02       Impact factor: 4.799

9.  Tissue transglutaminase (TG2) activity regulates osteoblast differentiation and mineralization in the SAOS-2 cell line.

Authors:  Xiaoxue Yin; Zhongqiang Chen; Zhongjun Liu; Chunli Song
Journal:  Braz J Med Biol Res       Date:  2012-04-26       Impact factor: 2.590

10.  Upregulation of transglutaminase and ε (γ-glutamyl)-lysine in the Fisher-Lewis rat model of chronic allograft nephropathy.

Authors:  Badri Shrestha; Imran Butt; Michelle Da Silva; Armando Sanchez-Lara; Bart Wagner; Andrew Raftery; Timothy Johnson; John Haylor
Journal:  Biomed Res Int       Date:  2014-07-21       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.